H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | 3 | $180,000 | $180,000 - $180,000 | 100.0% |
| ForgeRock, Inc. | 2 | $150,000 | $150,000 - $150,000 | 50.0% |
| ADVERUM BIOTECHNOLOGIES, INC. | 2 | $233,626 | $233,626 - $233,626 | 100.0% |
| LEVI STRAUSS & CO. | 2 | $209,517 | $185,408 - $233,626 | 100.0% |
| TWIST BIOSCIENCE CORPORATION | 1 | $223,270 | $223,270 - $223,270 | 100.0% |
| Tyler Technologies Inc | 1 | $109,000 | $109,000 - $109,000 | 100.0% |
| Eventus Advisory Group, LLC | 1 | $200,000 | $200,000 - $200,000 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 11 | $185,408 | $150,000 - $233,626 |
| Lead | 1 | $109,000 | $109,000 - $109,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| San Francisco | CA | 4 | $167,704 |
| Princeton | NJ | 2 | $180,000 |
| Redwood City | CA | 2 | $233,626 |
| Chino | CA | 1 | $200,000 |
| South San Francisco | CA | 1 | $223,270 |
| Irving | TX | 1 | $109,000 |
| New York | NY | 1 | $180,000 |
These roles are variations of Director, SEC Reporting with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Director, SEC Reporting and Technical Accounting | 6 | $205,087 | |
| Director, SEC Reporting | 5 | $183,807 | |
| SEC Reporting Lead | 1 | $109,000 | |
| SEC REPORTING/TECHNICAL ACCOUNTING SR. MANAGER | 1 | $130,000 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 1 | $185,408 | 100.0% |
| 2022 | 3 | $233,626 | 100.0% |
| 2023 | 3 | $180,000 | 66.7% |
| 2024 | 2 | $186,635 | 100.0% |
| 2025 | 3 | $180,000 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | 3 | $180,000 | 100.0% |
| ForgeRock, Inc. | 2 | $150,000 | 50.0% |
| ADVERUM BIOTECHNOLOGIES, INC. | 2 | $233,626 | 100.0% |
| LEVI STRAUSS & CO. | 2 | $209,517 | 100.0% |
| TWIST BIOSCIENCE CORPORATION | 1 | $223,270 | 100.0% |